Long-term safety, and efficacy of subcutaneous Efgartigimod PH20 in patients with generalized myasthenia gravis: interim results of ADAPT-SC

被引：2

作者：

Musick, K. ^{[1
]}

Howard, J. ^{[2
]}

Li, G. ^{[3
]}

Vu, T. ^{[4
]}

Korobko, D. ^{[5
]}

Smilowski, M. ^{[6
]}

Liu, L. ^{[1
]}

Steeland, S. ^{[1
]}

Noukens, J. ^{[7
]}

Van Hoorick, B. ^{[1
]}

Podhorna, J. ^{[1
]}

Li, Y. ^{[8
]}

Utsugisawa, K. ^{[9
]}

Sacca, F. ^{[10
]}

Wiendl, H. ^{[11
]}

De Bleecker, J. ^{[12
]}

Mantegazza, R. ^{[13
]}

机构：

[1] Argenx, Ghent, Belgium

[2] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA

[3] Medsol Clin Res Ctr Inc, Port Charlotte, FL USA

[4] Univ S Florida, Dept Neurol, Morsani Coll Med, Tampa, FL USA

[5] State Novosibirsk Reg Clin Hosp, State Budgetary Healthcare Inst Novosibirsk Reg, Novosibirsk, Russia

[6] Med Univ Silesia, Dept Hematol & Bone Marrow Transplantat, Katowice, Poland

[7] Curare Consulting BV, Hamburg, Germany

[8] Cleveland Clin, Cleveland, OH USA

[9] Hanamaki Gen Hosp, Dept Neurol, Hanamaki, Japan

[10] Federico II Univ Naples, NRSO Dept, Naples, Italy

[11] Univ Munster, Dept Neurol, Munster, Germany

[12] Ghent Univ Hosp, Ghent, Belgium

[13] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neuroimmunol & Neuromuscular Dis, Milan, Italy

来源：

NEUROMUSCULAR DISORDERS | 2023年 / 33卷

关键词：

D O I：

10.1016/j.nmd.2023.07.443

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P276

引用

页码：S179 / S179

页数：1

共 50 条

[1] Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC plus Study
Ritt, Elissa
Howard, James F., Jr.
Li, George
Vu, Tuan
Korobko, Denis
Smilowski, Marek
Liu, Li
Steeland, Sophie
Noukens, Jan
Van Hoorick, Benjamin
Podhorna, Jana
Li, Yuebing
Utsugisawa, Kimiaki
Sacca, Francesco
Wiendl, Heinz
De Bleecker, Jan L.
Mantegazza, Renato
ANNALS OF NEUROLOGY, 2023, 94 : S244 - S245
[2] Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC plus Study
Howard, James
Li, George
Vu, Tuan
Korobko, Denis
Smilowski, Marek
Liu, Li
Steeland, Sophie
Noukens, Jan
Van Hoorick, Benjamin
Podhorna, Jana
Li, Yuebing
Utsugisawa, Kimiaki
Sacca, Francesco
Wiendl, Heinz
De Bleecker, Jan
Mantegazza, Renato
NEUROLOGY, 2023, 100 (17)
[3] LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF SUBCUTANEOUS EFGARTIGIMOD PH20 IN PARTICIPANTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT-SC plus STUDY
Li, Yuebing
Howard, James F., Jr.
Vu, Tuan
Korobko, Denis
Steeland, Sophie
Van Hoorick, Benjamin
Podhorna, Jana
Hodari, Moana
Utsugisawa, Kimiaki
Sacca, Francesco
De Bleecker, Jan L.
Mantegazza, Renato
MUSCLE & NERVE, 2024, 70 (03) : 559 - 560
[4] LONG-TERM SAFETY AND EFFICACY OF EFGARTIGIMOD PH20 SC IN GENERALIZED MYASTHENIA GRAVIS: INTERIM ANALYSIS OF ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY SERONEGATIVE PARTICIPANTS IN ADAPT-SC
Bhavaraju-Sanka, Ratna
Howard, James F., Jr.
Vu, Tuan
De Bleecker, Jan L.
Utsugisawa, Kimiaki
Pasnoor, Mamatha
Sacca, Francesco
Korobko, Denis
Steeland, Sophie
Noukens, Jan
Van Hoorick, Benjamin
Liu, Li
Podhorna, Jana
Meisel, Andreas
Mantegazza, Renato
MUSCLE & NERVE, 2024, 70 (03) : 516 - 517
[5] Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC plus )
Howard Jr, James F.
Vu, Tuan
Li, George
Korobko, Denis
Smilowski, Marek
Liu, Li
Gistelinck, Fien
Steeland, Sophie
Noukens, Jan
Van Hoorick, Benjamin
Podhorna, Jana
Borgions, Filip
Li, Yuebing
Utsugisawa, Kimiaki
Wiendl, Heinz
De Bleecker, Jan L.
Mantegazza, Renato
NEUROTHERAPEUTICS, 2024, 21 (05)
[6] Long-term Safety and Efficacy of Efgartigimod in Patients With Generalized Myasthenia Gravis: Interim Results of the ADAPT plus Study
Howard, James
Bril, Vera
Vu, Tuan
Karam, Chafic
Peric, Stojan
De Bleecker, Jan
Murai, Hiroyuki
Meisel, Andreas
Beydoun, Said
Pasnoor, Mamatha
Guglietta, Antonio
Ulrichts, Peter
T'joen, Caroline
Brauer, Edward
Utsugisawa, Kimiaki
Verschuuren, Jan
Mantegazza, Renato
NEUROLOGY, 2022, 99 (23) : S37 - S38
[7] LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY
Howard, James F., Jr.
Bril, Vera
Tuan Vu
Karam, Chafic
Peric, Stojan
De Bleecker, Jan L.
Murai, Hiroyuki
Meisel, Andreas
Beydoun, Said
Pasnoor, Mamatha
Guglietta, Antonio
T'joen, Caroline
Utsugisawa, Kimiaki
Verschuuren, Jan
Mantegazza, Renato
MUSCLE & NERVE, 2022, 65 : S9 - S10
[8] LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY
Howard, James
Bril, Vera
Tuan Vu
Karam, Chafic
Peric, Stojan
De Bleecker, Jan
Murai, Hiroyuki
Meisel, Andreas
Beydoun, Said
Pasnoor, Mamatha
Guglietta, Antonio
T'joen, Caroline
Utsugisawa, Kimiaki
Mantegazza, Renato
MUSCLE & NERVE, 2022, 66 : S57 - S57
[9] Dose Selection and Clinical Development of Efgartigimod PH20 Subcutaneous in Patients with Generalized Myasthenia Gravis
Li, George
Li, Yuebing
Vu, Tuan
Korobko, Denis
Smilowski, Marek
Liu, Li
Steeland, Sophie
Van Hoorick, Benjamin
Podhorna, Jana
Casey, Jenna
Noukens, Jan
Van Bragt, Tonke
Utsugisawa, Kimiaki
Wiendl, Heinz
De Bleecker, Jan
Mantegazza, Renato
Howard, James
NEUROLOGY, 2023, 100 (17)
[10] DOSE SELECTION AND CLINICAL DEVELOPMENT OF EFGARTIGIMOD PH20 SUBCUTANEOUS IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
Guptill, Jeffrey
Li, Yuebing
Vu, Tuan
Korobko, Denis
Liu, Li
Steeland, Sophie
Van Hoorick, Benjamin
Podhorna, Jana
Brauer, Eddie
Noukens, Jan
Van Bragt, Tonke
Utsugisawa, Kimiaki
De Bleecker, Jan L.
Howard, James
MUSCLE & NERVE, 2024, 70 (03) : 705 - 705

← 1 2 3 4 5 →